Katherine Green - July 9, 2025 Most opposed companies at the EPO in 2024 Opposition activity at the European Patent Office is often a strong indicator of a technology’s ...
Matthew Naylor - July 7, 2025 UPC Weekly - Extra time, suspensions and replays. Part II – suspensive effect 2025 Week 27 Last week, we looked at how the UPC deals with requests for extensions of time. This ...
Matthew Naylor - June 30, 2025 UPC Weekly - Extra time, suspensions and replays. Part I – extensions of time 2025 Week 26 This is the first in a miniseries of reviews of some hands-on, coalface practice of ...
Katherine Green - June 30, 2025 Most opposed patents of 2024 The list is, again, dominated by patents for therapeutic treatments, although the trends seen last ...
Sarah Harvey - June 25, 2025 Combatting AMR in UTIs Urinary tract infections (UTIs) are among the most common bacterial infections, affecting millions ...
Eliot Ward - June 23, 2025 UPC Weekly - 10x Genomics v. Curio Bioscience – When is an array no longer an array? 2025 Week 25 Düsseldorf Local Division follows its preliminary finding and decides that Curio’s kit ...
Matthew Naylor - June 16, 2025 UPC Weekly - Where have we got to with the UPC doctrine of equivalents? 2025 Week 24 It’s often the thorniest substantive question in patent litigation, and by extension ...
Matthew Naylor - June 9, 2025 UPC Weekly - Playing the longer game – patentee wins on the merits after a failed PI 2025 Week 23 Sometimes you need to know when to take a step back from enforcing your patent, and ...
Joanna Smith - June 3, 2025 Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2025 We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent ...
Lucy Coe - June 2, 2025 UPC Weekly - Using parallel UPC and EPO proceedings as a strategic tool 2025 Week 22 As we enter the third year of the UPC, we are seeing more and more parallel UPC ...
Matthew Naylor - May 27, 2025 UPC Weekly - Juicer patent: no additives but no invention 2025 Week 21 In April 2024, Korean kitchen appliance firm Hurom launched patent infringement ...
Eliot Ward - May 19, 2025 UPC Weekly - ‘Off label’ and off the hook: UPC finds no infringement of second medical use patent 2025 Week 20 For many years, the EPO has recognised that the novelty and inventiveness of a ...
Matthew Naylor - May 12, 2025 UPC Weekly - UPC preliminary injunction proceedings – a big stick even if denied? 2025 Week 19 Your patent is valid and in force. The alleged infringement falls squarely inside the ...
Matthew Naylor - May 6, 2025 UPC Weekly - UPC Court of Appeal imposes preliminary injunction based on a fresh claim interpretation 2025 Week 18 The UPC Court of Appeal has had its fair share of preliminary injunction (PI) cases. A ...
Matthew Naylor - April 28, 2025 UPC Weekly - Costs at the UPC – some sharp edges to watch out for 2025 Week 17 This week we take a look at how the winning party at the UPC should apply for their ...
Matthew Naylor - April 22, 2025 UPC Weekly - The saisie out of the recycling bin 2025 Week 16 After an initial flurry and then a plateau, the cumulative number of applications for ...
Lucy Coe - April 14, 2025 UPC Weekly - Infringement of product-by-process at the UPC 2025 Week 15 Another first from the UPC this week – how to go about deciding on infringement and ...
Matthew Naylor - April 7, 2025 UPC Weekly - Hey, why don’t we all just use the problem-solution approach? 2025 Week 14 It’s been a big week at the UPC. So many decisions issued that normally it would be a ...
Matthew Naylor - March 24, 2025 UPC Weekly - Some plain speaking from the UPC – on its existence and ambushes 2025 Week 12 There used to be a great rule-of-thumb for reading the headlines of certain British ...
Matthew Naylor - March 17, 2025 Historical infringement at the UPC and selecting remedies à la carte 2025 Week 11 The UPC has already made it clear that you can sue for damages for patent infringement ...
Matthew Naylor - March 10, 2025 UPC Weekly - UPC Court of Appeal adds more colour to preliminary injunction decisions 2025 Week 10 We love having a couple of contrasting UPC decisions here at UPC Weekly. This time we ...
Matthew Naylor - March 3, 2025 UPC Weekly - The wood chipper, the restoration and the avalanche rescue sequel 2025 Week 9 There are three cases in the mix for discussion this week. First we look at an ...
Matthew Naylor - February 24, 2025 UPC Weekly - UPC Court of Appeal takes a new approach to assessing added subject matter 2025 Week 8 It has always been clear that the UPC Court of Appeal (UPC CoA) would have a hugely ...
Matthew Naylor - February 17, 2025 UPC Weekly - Secrets and files 2025 Week 7 One of the richest seams of UPC procedural case law so far is all about how parties can ...
Matthew Naylor - February 10, 2025 UPC Weekly - Two infringement actions, only one counterclaim for revocation, and an EPO opposition with rocket boosters 2025 Week 6 Lenovo/Motorola and Ericsson are battling it out in an ongoing global dispute about 5G ...
Matthew Naylor - February 3, 2025 UPC Weekly - The UPC’s long arm jurisdiction balances against a strict approach to validity 2025 Week 5 Long before the UPC opened its doors for business, there was speculation about whether ...
Matthew Naylor - January 27, 2025 UPC Weekly - No second bite of the cherry for an intervener at the UPC 2025 Week 4 In the usual run of patent litigation, there is a claimant and a defendant and the rest ...
Matthew Naylor - January 20, 2025 UPC Weekly - Damages and added matter at the UPC 2025 Week 3 The UPC has most definitely kicked into gear. Each week there are increasing numbers of ...
Eliot Ward - January 13, 2025 UPC Weekly - Alexion v Samsung & Amgen – Patentee’s attempted U-turn on claim interpretation foiled by UPC Court of Appeal 2025 Week 2 Tailoring one’s claim interpretation for the jurisdiction at hand can be a canny way of ...
Matthew Naylor - January 6, 2025 UPC Weekly - UPC transparency by numbers 2025 Week 1 How easy is it to get hold of documents from UPC cases? The easy answer “it depends” is ...
Matthew Naylor - December 30, 2025 UPC Weekly - Pay to play at the UPC 2024 Week 52 Both Apple and Google have recently succeeded in persuading the UPC Local Division ...
Matthew Naylor - December 23, 2024 UPC Weekly - UPC gets tough with penalty payment orders 2024 Week 51 Great – the UPC has just decided that your patent is valid and infringed. You get an ...
Anthony Judd - December 18, 2024 New EPO sanctions against Russia As reported here, in late June 2024 the European Union (EU) extended their package of sanctions in ...
Matthew Naylor - December 16, 2024 UPC Weekly - The 9 second rule at the UPC 2024 Week 50 Does it matter who gets to the doors of the UPC first? Does it matter if you get there ...
Matthew Naylor - December 9, 2024 UPC Weekly - Very appealing – preliminary injunction overturned 2024 Week 49 SharkNinja have managed to persuade the UPC Court of Appeal to overturn a preliminary ...
Matthew Naylor - December 2, 2024 UPC Weekly - Front-loading and obviousness at the UPC 2024 Week 48 In NJOY v VMR, the UPC Central Division Paris revoked VMR’s patent EP 3456214 B2 on 27 ...
Matthew Naylor - November 25, 2024 UPC Weekly - UPC finds infringement using a doctrine of equivalents 2024 Week 47 Back in June 2024 (UPC Weekly 2024 week 23), we set out a few “known unknowns” – ...
Emily Lythell - November 21, 2024 Resistance is futile – how new tech tackles AMR Antimicrobial resistance (AMR) refers to the ability of microorganisms—bacteria, viruses, fungi, ...
Matthew Naylor - November 18, 2024 UPC Weekly - UPC dials up the advantages for patentees 2024 Week 46 We report this week on two new UPC decisions that make the UPC an even more attractive ...
Matthew Naylor - November 11, 2024 UPC Weekly - NJOY duel with Juul 2024 Week 45 5 November 2024 saw two decisions handed down by the UPC Paris Central Division (CD) ...
Matthew Naylor - November 4, 2024 UPC Weekly - All of the fizz and none of the squeeze 2024 Week 44 SodaStream v Aarke is a decision on the merits of an infringement case based on EP ...
Matthew Naylor - October 28, 2024 UPC Weekly - UPC confirms approach to inventive step for life science inventions 2024 Week 43 10x Genomics and NanoString have been duking it out at the UPC since the court opened ...
Rebecca Tollervey - October 28, 2024 Claim Requests found Inadmissible in EPO Appeal Proceedings: What Can Proprietors Do? Since the EPO’s Rule of Procedure of the Boards of Appeal (RPBA) were revised in 2020, parties have ...
Matthew Naylor - October 21, 2024 UPC Weekly - Light emitting diode patent falls into a black hole of invalidity 2024 Week 42 Last week we did a deep dive into some LED technology to explain the decision of the ...
Joanna Smith - October 17, 2024 Chambers & Partners 2025 legal guide - Band 1 We are proud to have once again been ranked Band 1 (gold) in Chambers & Partners 2025 legal ...
Matthew Naylor - October 14, 2024 UPC Weekly - A pro-patent decision on infringement and validity 2024 Week 41 This week we report on Seoul Viosys v Expert Klein, a full decision on infringement ...
Matthew Smith - October 11, 2024 Mewburn Ellis is proud to have co-hosted the London week of the JIPA European Seminar 2024! This week, we were proud to welcome 14 Japanese Patent Attorneys from various companies in Japan as ...
Tom Furnival - October 8, 2024 Most opposed medical device companies at the EPO 2023 Following on from our recent post on the Most Opposed Companies at the EPO 2023 we’ve broken that ...
Niles Beadman - October 7, 2024 Battery Manufacturing: Funding the Future In September, the US Department of Energy announced the latest round of funding to electrify the ...
Matthew Naylor - October 7, 2024 UPC Weekly - Costs: the UPC’s Big Lever 2024 Week 40 This week we report on a UPC Court of Appeal decision that focuses only on costs, and ...
Joanna Smith - October 2, 2024 Mewburn Ellis: top tier firm Legal 500 2025 We are extremely proud to once again be ranked tier one for our patent and trade mark practices in ...
Matthew Naylor - September 30, 2024 UPC Weekly - UPC Court of Appeal digs into the detail in a new preliminary injunction case 2024 Week 39 Outdoor equipment makers Ortovox and Mammut are locked in a UPC battle about avalanche ...
Matthew Naylor - September 23, 2024 UPC Weekly - The first UPC SEP injunction 2024 Week 38 On 13 September 2024, the UPC Munich Local Division handed down its decision in the ...
Matthew Smith - September 19, 2024 Mewburn Ellis is delighted to co-host London week of the JIPA European Seminar 2024! We are looking forward to co-hosting the London week of the JIPA F4 Course (European patent ...
Katherine Green - September 17, 2024 Most opposed companies at the EPO 2023 The European Patent Office grants about 100,000 patents per year (EPO Statistics here). The grant ...
Matthew Naylor - September 16, 2024 UPC Weekly - Clearing the way can lead to UPC bifurcation and language complexities 2024 Week 37 Let’s say that you are a company based outside Europe and intend to launch a new ...
Matthew Naylor - September 9, 2024 UPC Weekly - UPC preliminary injunctions – a top-up 2024 Week 36 Just two weeks ago we reviewed UPC case law on preliminary injunctions (PIs), giving ...
Alex Galbraith - September 4, 2024 We perform significantly better than the EPO average at oppositions We really are experts when it comes to opposing patents and our enviable success rate speaks for ...
Lucy Coe - September 2, 2024 UPC Weekly - Let’s brake for a minute, and talk about Tesla 2024 Week 35 Last week saw two decisions handed down from the UPC Local Divisions as part of ...
Emma Kennaugh-Gallacher - August 27, 2024 UPC Weekly - UPC Preliminary Injunctions – Background, Trends and Lessons Learned 2024 Week 34 No-one wants to be on the receiving end of a UPC preliminary injunction. The tussles ...
Matthew Naylor - August 19, 2024 UPC Weekly - Revisiting transparency of UPC proceedings 2024 Week 33 The UPC has been doing a lot of stuff right. Litigators praise the preparedness of the ...
Nick Sutcliffe - August 13, 2024 Cellular agriculture – increasing importance of IP in cultivated meat As the cultivated meat industry matures, consolidation is widely anticipated due to increasing ...
Sean Jauss - August 12, 2024 UPC Weekly - Now let’s talk about saisies 2024 Week 32 There is no discovery at the UPC.
Matthew Naylor - August 5, 2024 UPC Weekly - UPC revocation versus EPO opposition – playing out in not-so-slow-mo 2024 Week 31 What happens when you have the same parties fighting over revocation of the same ...
Andrew Mears - August 1, 2024 Navigating the Dual Pathways: Regulatory Approval and Patent Protection for Medical Devices For medical device manufacturers and designers, the journey to market success hinges on two crucial ...
Matthew Naylor - July 29, 2024 UPC Weekly - Where’s your UPC off-ramp? 2024 Week 30 Every litigator needs to have a clear view of the possible routes out of litigation. ...
Jeremy Webster - July 26, 2024 Meet the team: Jeremy Webster, Partner, Head of Chemistry As part of our 'meet the team' series, we talk to partner and head of chemistry, Jeremy Webster, ...
Thomas Wolter - July 22, 2024 UPC Weekly - UPC Munich Central Division sets out a marker on how the UPC should approach inventive step 2024 Week 29 This week saw the first UPC decision on the merits issued in the long-running patent ...
Lesley Gardner - July 18, 2024 National Paralegal Awards Finalists 2024 We are extremely proud to announce our finalists in the National Paralegal Awards 2024 which ...
Rebecca Tollervey - July 16, 2024 EPO case law for antibodies – 2024 update In 2023 we published a pair of articles reviewing EPO case law in the field of antibodies, ...
Matthew Naylor - July 15, 2024 UPC Weekly - UPC Local Divisions - the reluctant bifurcators 2024 Week 28 This week we look at how the UPC is handling requests to split substantive ...
Matthew Naylor - July 8, 2024 UPC Weekly - UPC overturns EPO opposition division decision on the same prior art 2024 Week 27 In the race to be the first UPC division to produce a written decision on a main ...
Matthew Naylor - July 1, 2024 UPC Weekly - Three month delay fatal for a preliminary injunction application 2024 Week 26 On 3 June 2024, the UPC Local Division in Hamburg decided to refuse a preliminary ...
Joanna Smith - June 28, 2024 More recognition in MIP IP Stars 2024 It is fantastic to once again be recognised in MIP IP Stars 2024. So far this year, we have ...
Jane Liu - June 25, 2024 Alive with Possibilities - The Future of Sustainable Plastics and Beyond As the production and consumption of plastics continues to surge, so too has the accumulation of ...
Matthew Naylor - June 24, 2024 UPC Weekly - UPC uses EPO approach to added subject matter 2024 Week 25 There was lots of UPC news to hold the interest this week but for me the standout was ...
Matthew Naylor - June 17, 2024 UPC Weekly - Opting-out from the UPC: the Who, the When and the Why 2024 Week 24 It seems like a long time ago now, but from March to May 2023, the “sunrise period” of ...
Adam Gregory - June 17, 2024 Podcast with Adam Gregory: protecting innovations in the biotech space Adam Gregory joins John Joson Ng on Nucleate Singapore’s Pulse podcast where he highlights success ...
Eliot Ward - June 14, 2024 How helpful are biological deposits at the EPO? In our article about biological deposits under the Budapest Treaty, we explored the deadlines and ...
Matthew Naylor - June 10, 2024 UPC Weekly - Three Known Unknowns at the UPC 2024 Week 23 It’s a bit risky to write a blog where you hope it will go out of date quickly. But ...
Joanna Smith - June 10, 2024 Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2024 We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent ...
Eliot Ward - June 5, 2024 Unitary patent and UPC to cover Romania from 1 September 2024 The first enlargement of the UPC and Unitary Patent (UP) territory will happen on 1 September 2024, ...
Sean Jauss - June 3, 2024 1st Anniversary of the UPC – some stats! The Unified Patent Court (UPC) celebrated its first anniversary on 1 June 2024. The Court is busy. ...
Matthew Naylor - June 3, 2024 UPC Weekly - Should we stay or should we go on? 2024 Week 22 This week we report on the UPC revocation action in Bitzer v. Carrier and the related ...
Matthew Naylor - May 28, 2024 UPC Weekly - Let’s talk about costs 2024 Week 21 This week we focus how the UPC is dealing with requests for security for costs and the ...
Matthew Naylor - May 20, 2024 UPC Weekly - UPC Court of Appeal confirms their own case law on claim interpretation but sidesteps question of file wrapper estoppel 2024 Week 20 The UPC Court of Appeal have issued another decision on a preliminary injunction – ...
Matthew Naylor - May 13, 2024 UPC Weekly - High bar to challenge the jurisdiction of the UPC 2024 Week 19 This week saw the UPC issue two decisions about its own jurisdiction. Where a ...
Matthew Naylor - May 7, 2024 UPC Weekly - Preliminary injunctions at the UPC – get your defence ready 2024 Week 18 This week we look at a recent UPC first instance decision for a preliminary ...
Matthew Naylor - April 29, 2024 UPC Weekly - Battling the Biosimilars: opt-outs, preliminary injunctions & protective letters 2024 Week 17 This week we delve into the details of the first two UPC disputes involving ...
Eleanor Maciver - April 26, 2024 Cleantech Commercialisation Report: Highlights and Trends Today (26 April 2024) the European Patent Office (EPO) and the European Investment Bank (EIB) ...
Matthew Naylor - April 22, 2024 UPC Weekly - Language of proceedings at the UPC 2024 Week 16 This week we focus on the language of proceedings at the UPC, considering when the ...
Matthew Naylor - April 15, 2024 UPC Weekly - Time-dependent transparency of UPC proceedings? 2024 Week 15 The week saw the Court of Appeal issue its decision on public access to court file ...
Matthew Naylor - April 10, 2024 UPC Weekly - Mind your costs 2024 Week 14 The UPC Court of Appeal issued a collection of five appeal decisions on 3 April 2024 ...
Matthew Naylor - April 3, 2024 Public access to UPC proceedings When the UPC was set up, a basic tenet was set out in Article 45 of the UPC Agreement, that the ...
Anthony Judd - April 2, 2024 EPO related support measures for small entities – 1 April 2024 INTRODUCTION From 1 April 2024, the EPO are introducing a new fee reduction scheme specifically for ...
Lucy Coe - March 11, 2024 Challenging patents and other clearance actions in Europe Whether it is to remove a current infringement threat, clear the way to reduce the risk in ...
Daniel Brodsky - March 8, 2024 Robotics in surgery For many, the word ‘surgery’ suggests images of surgeons operating with handheld instruments ...
Laura Pediani - March 6, 2024 Meet the team: Laura Pediani, Patent Paralegal As part of our 'meet the team' series, we talk to paralegal Laura Pediani about client service, ...
Nick Sutcliffe - March 4, 2024 Cellular Agriculture – Innovating through the Challenges The last year (2023) has seen a difficult environment for Cellular Agriculture (Cell Ag) companies ...
Rebecca Brooks - February 29, 2024 Updates to the Guidelines for Examination at the EPO The Guidelines for Examination at the EPO (which will be referred to as “the Guidelines” in this ...
Rebecca Tollervey - February 22, 2024 Antibody inventions: Updates in the EPO Guidelines for Examination The EPO Guidelines for Examination are set to undergo updates effective from 1 March 2024. The ...
Eliot Ward - February 21, 2024 Biological Deposits under the Budapest Treaty (1977): important considerations for filing strategies and public accessibility Biological material, which the EPO understands to be any material containing genetic information ...
Tom Furnival - February 14, 2024 The major players in the SEP landscape in Europe Next in our series of blogs, we have investigated the major players in the SEP landscape in Europe.
Anthony Judd - February 6, 2024 EPO announces fee increases from 1 April 2024 In recent times, the European Patent Office (EPO) has increased its official fees every two years, ...
Katherine Green - February 2, 2024 Most opposed patents of 2023 Multiple sclerosis therapies are the subject of two of the most opposed patents of 2023. Novartis’ ...
Jacqueline Murphy - January 18, 2024 Design Rights: A powerful tool in the IP armoury We are pleased to launch our latest special report Design Rights: A powerful tool in the IP ...
Sophie Chua - January 16, 2024 Gigafactories & IP: Protecting the processes that power the future As the use of electric vehicles (EVs) becomes increasingly prevalent, demand for batteries is set ...
Joseph Newcombe - December 19, 2023 The Royal Institution's new mission With 1.4 million subscribers on YouTube, the organisation is finding new ways to enthuse the ...
Tom Furnival - December 19, 2023 How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? – Part 3 This article continues our series of blogs investigating whether or not declaring your patent or ...
Ben Boyd - December 19, 2023 Sailing cargo You might question why an IP firm concerned with innovation is writing about the use of sails in ...
Ben Boyd - December 5, 2023 Ballast-free ships While this blog is about ballast-free ships, it is important to understand why cargo ships require ...
Niles Beadman - November 28, 2023 Invention Capture: 5 Steps to Success - Transforming Technology to Patent Protection Invention capturing, also referred to as invention harvesting or invention mining, is the start of ...
Alex Burns - November 28, 2023 Emotional Perception AI v UKIPO: Is this the dawning of a new era for AI-related inventions at the UKIPO? On 21 November 2023, Mann J handed down his judgment on Emotional Perception AI Ltd v ...
Ben Boyd - November 23, 2023 Tidal energy Most people are aware that the moon (and to a lesser extent the sun), exert a gravitational pull on ...
Ben Boyd - November 14, 2023 Salinity gradient power In this series on capturing energy from the ocean we’ve recently discussed wave power, tidal power ...
Katherine Green - November 13, 2023 Most opposed patents of 2022 As with CRISPR, patents directed to Nobel Prize-winning technologies are viewed as extremely ...
Jacqueline Murphy - November 8, 2023 Validating European patents outside Europe - the Validation State system We are pleased to launch our latest report Validating European patents outside Europe - the ...
Ben Boyd - November 7, 2023 Is Ocean Thermal Energy Conversion a sustainable way forward? We’ve previously discussed how energy can be captured directly from the movement of the waves on ...
Joanna Smith - October 19, 2023 Chambers & Partners 2024 legal guide - Band 1 We are proud to have once again been ranked Band 1 (gold) in Chambers & Partners 2024 legal ...
Joanna Smith - October 5, 2023 Mewburn Ellis: top tier firm Legal 500 2024 We are extremely proud to once again be ranked tier one for our patent and trade mark practices in ...
Eliot Ward - October 4, 2023 UPC at four months old - a review The UPC is now four months old and the Court of First Instance is already quite busy. As of 4 ...
Sean Jauss - September 29, 2023 Beware the front-loaded procedure! The Unified Patent Court (‘UPC’) opened its doors on 1 June 2023. It is a new court in the European ...
Matthew Smith - September 8, 2023 Trends in Graphene IP – a refresh Last year, we delved into the data to see how the number of patent publications coming out had ...
Hojae Lee - August 30, 2023 Updates on the Korean Intellectual Property Office (KIPO) fee structure, effective 1 August 2023 If you have patents or trade marks in Korea or are considering filing or transferring them, you ...
Fynn McLennan - August 21, 2023 Silicon anodes: where are we now? In 2020, we wrote about some of the approaches being taken to develop viable silicon-based anodes. ...
James Leach - August 16, 2023 Quick guide to determining whether a software invention is patent eligible. In general, the main obstacle to obtaining patent protection for a new software invention is the ...
Tom Furnival - August 10, 2023 UPC as a forum for SEP disputes – Panasonic kick off proceedings With the UPC opening its doors just over two months’ ago, the IP profession has been keenly ...
Lesley Gardner - July 26, 2023 National Paralegal Awards Finalists 2023 We are extremely proud to announce our finalists in the National Paralegal Awards 2023 which ...
Jacqueline Murphy - July 18, 2023 Does Green IP mean go? Exploring acceleration under the UKIPO’s “Green Channel” We are pleased to launch our latest report Does Green IP mean go? Exploring acceleration under the ...
Thomas Wolter - July 6, 2023 Beating the Punch: UPC Protective Letters The Unified Patent Court (UPC) is now operational. As of June 1, 2023, patentees can enforce ...
Sean Jauss - July 5, 2023 Litigation in the Unified Patent Court (UPC) The UPC is a new European patent litigation court. It will provide a single forum for the ...
Ben Boyd - July 5, 2023 Big Data in Maritime transport Big data has been a big thing for most of the last decade, yet its importance in industry continues ...
Joanna Smith - July 4, 2023 Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Sean Jauss - June 27, 2023 UPC Administrative Committee approves Milan as host of the third Central Division court The UPC Administrative Committee has announced that Milan will host the third seat of the UPC’s ...
David Fyfield - June 19, 2023 IPEC Small Claims moving to Manchester The Presiding Judge of the Intellectual Property Enterprise Court (‘IPEC’) has issued a Practice ...
Rob Walker - June 7, 2023 World Ocean Day 2023 – Turning the Tide on Ocean Pollution 8 June 2023 marks the 21st World Ocean Day, which, in the words of The Ocean Project, has a mission ...
Joanna Smith - June 6, 2023 More recognition in MIP IP Stars 2023 It is fantastic to once again be recognised in MIP IP Stars 2023. So far this year, we have ...
Jacqueline Murphy - May 16, 2023 Green Tech: Making IP Part of Your Toolkit - Webinar On Wednesday 21 June, we are delighted to be hosting in partnership with Oxfordshire Greentech a ...
Rebecca Tollervey - May 9, 2023 Patenting antibodies – the latest developments from the EPO Boards of Appeal: Part 2 – inventive step We have conducted a review of Board of Appeal decisions relating to antibody patents published ...
Joanna Smith - May 5, 2023 Mewburn Ellis shortlisted for two awards at the Managing IP EMEA Awards 2023 We are delighted to have been nominated in two categories by Managing IP at their EMEA Awards.
Rob Walker - May 2, 2023 The History of Hydrofoils Since their introduction into the America’s Cup boats in 2013, hydrofoils have become familiar to ...
Andy King - April 28, 2023 Fail to Prepare; Prepare to Fail: a discussion about representation issues at the UK IPO The UK IPO has recently introduced an important change to the rules on representation of certain ...
Darena Slavova - April 25, 2023 EPO to Abolish “10-Day Rule” from 01 November 2023 Key Points: the “10-day rule” will be abolished and will not be applied in respect of European ...
Thea Toutoungy - April 21, 2023 The lithium rush: an unsustainable approach to sustainability? In recent years, the world has seen the significant consequences of our continued heavy dependence ...
Jacqueline Murphy - April 19, 2023 Operating in the circular economy: From idea to Business – our co-hosted event with Oxfordshire Greentech On Wednesday 22 March, we were delighted to co-host an in-person event with Oxfordshire Greentech ...
Ben Boyd - April 17, 2023 Offshore winds blow against Siemens Late last year Siemens Gamesa Renewable Energy A/S was unsuccessful in asserting infringement of ...
Alison Fugard - April 14, 2023 “Wood”n’t it be nice? - Turning over a new leaf in wood-based packaging For years, we have been aware of the need to reduce our reliance on plastic. But there is a reason ...
Ben Boyd - April 14, 2023 Patents at sea Patents are a territorial right. A UK patent provides you with a monopoly right for your claimed ...
Robert Watson - March 31, 2023 UK accession to the CPTPP - grace period exemption big boost for IP The UK government announced 5 years ago its intention to join the CPTPP (Comprehensive and ...
Ben Boyd - March 21, 2023 Motion of the ocean - Wave energy converters The ocean covers 70% of the earth’s surface, so it is no wonder there is a significant attention at ...
Matthew Barton - March 3, 2023 Conservation innovation – working towards a world for both humans and wildlife With a rapidly growing human global population, predicted to reach 10 billion by 2057, our impact ...
Urs Ferber - March 1, 2023 Unified Patent Court (UPC) FAQS – how do we make sure an opt-out request is valid? The delay of the opening of the Unified Patent Court (UPC) gives us some additional time to reflect ...
Niles Beadman - February 21, 2023 Faraday Battery Challenge: Funding the Future Michael Faraday uncovered the link between electricity and magnetism, built the first electric ...
Samuel Hart - February 17, 2023 EPO announces fee increases from 1 April 2023 In recent times, the European Patent Office (EPO) has increased its official fees every two years. ...
Urs Ferber - February 13, 2023 Unified Patent Court (UPC) FAQS – who is entitled to file an opt-out request? The delay of the opening of the Unified Patent Court (UPC) gives us some additional time to reflect ...
Callum McGuinn - February 8, 2023 Meet the team: Callum McGuinn, Partner and Patent Attorney in the Chemistry team, London As part of our 'meet the team' series, we talk to Callum McGuinn about his journey to becoming a ...
Julie Carlisle - February 5, 2023 Meet the team: Julie Carlisle, Partner, Patent Attorney and Litigator in the Chemistry team, London As part of our 'meet the team' series, we talk to Julie Carlisle about her journey to becoming a ...
Emma Graham - February 2, 2023 Meet the team: Emma Graham, Partner and Patent Attorney in the Engineering team, London As part of our 'meet the team' series, we talk to Emma Graham about her love of patent drafting, ...
Emma Graham - February 1, 2023 Should I file third party observations? A study of the consequences of filing third party observations (TPOs) in the MedTech sector and the ...
Rebecca Tollervey - February 1, 2023 Patenting antibodies – the latest developments from the EPO Boards of Appeal The prosecution of patent applications relating to antibodies involves particular considerations. ...
Camille Terfve - January 31, 2023 Meet the team: Camille Terfve, Partner and Patent Attorney in the Life Sciences team, Cambridge As part of our 'meet the team' series, we talk to Camille Terfve about her journey to becoming a ...
Eleanor Maciver - January 24, 2023 Meet the team: Eleanor Maciver, Partner and Patent Attorney in the Chemistry team, Cambridge As part of our 'meet the team' series, we talk to Eleanor Maciver about her journey to becoming a ...
Christopher Casley - January 20, 2023 Meet the team: Christopher Casley, Partner and Patent Attorney in the Life Sciences team, Bristol As part of our 'meet the team' series, we talk to Christopher Casley about why he enjoys life as a ...
Jacqueline Murphy - January 9, 2023 Operating in the circular economy: From idea to Business – in person event, Oxford UK, 22 March 2023 We are delighted to be partnering with Oxfordshire Greentech to present an exciting new in person ...
Jacqueline Murphy - November 29, 2022 Patent Litigation Trends in England & Wales - new report We are delighted to release our latest report Patent Litigation Trends in England and Wales.
Thomas Wolter - November 21, 2022 Plausibility and Inventive Step at the EPO - Watch G2/21 live on Thursday 24 November On Thursday 24 November 2022, the Enlarged Board of Appeal (EBA) will hear the parties in case ...
Paul Dunne - November 1, 2022 Meet the team: Paul Dunne, Partner and Patent Attorney in the Chemistry team, Bristol As part of our 'meet the team' series, we talk to Paul Dunne about his journey to becoming a patent ...
Darena Slavova - November 1, 2022 EPO introduces top-up searches for earlier national rights On 1 September 2022, the EPO introduced an extra “quality check” prior to granting a European ...
Jacqueline Murphy - October 25, 2022 Top Tier in Chambers & Partners 2023 legal guide We are proud to have once again been ranked Band 1 (gold) in Chambers & Partners 2023 legal ...
Jacqueline Murphy - October 25, 2022 Graphene: patenting a wonder material Our Special Report Graphene: patenting a wonder material examines graphene-related patent ...
Jacqueline Murphy - October 14, 2022 Mewburn Ellis: top tier firm Legal 500 2023 We are extremely proud to be ranked tier one for our patent and trade mark practices in the 2023 ...
Maria Hall - October 14, 2022 Robert Watson elected President of FICPI’s Study and Work Committee Partner Robert Watson was elected President of FICPI’s Study and Work Committee (Commission d'Etude ...
Matthew Naylor - September 23, 2022 UPC: Rules of Procedure finalised and in force The Unitary Patent Court now has a revised set of Rules of Procedure. These came into force on 1 ...
Eliot Ward - September 22, 2022 Mewburn Ellis launch Validation Costs Estimator Tool We are pleased to launch our new Validation Costs Estimator Tool. We know that it can be ...
Emma Kennaugh-Gallacher - September 21, 2022 Non-Fungible Tokens as legal property? The world of cryptocurrency is a fast-moving and complex one. Cryptocurrencies such as Bitcoin have ...
Charlotte Lynch - August 16, 2022 Standards, SEPs, and FRAND agreements - an overview The terms “standards,” “SEPs,” and “FRAND agreements,” are increasingly being mentioned in the ...
Richard Johnson - August 8, 2022 IP as an enabler for AI: UK government shows its hand The recently published response of the UK government to a consultation on the interface between ...
Katherine Green - July 28, 2022 Most opposed patents of 2021 When we reviewed our list of the most opposed European patents of 2021, we found that the patent at ...
Eliot Ward - July 19, 2022 Unitary Patent Package - an overview In this Forward: On Demand vlog, Eliot Ward gives us an overview of the Unitary Patent Package, ...
Jacqueline Murphy - July 4, 2022 Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2022 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Thomas Wolter - June 27, 2022 EPO presses pause on proceedings that depend on the plausibility referral to the EBA Despite not having any express legislative basis in the European Patent Convention, plausibility ...
Jacqueline Murphy - June 23, 2022 Mewburn Ellis win MIP UK Patent Prosecution Firm of the Year! We are delighted to have been named UK Firm of the Year for Patent Prosecution at the Managing IP ...
Jacqueline Murphy - June 20, 2022 Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2022 We are delighted to once again be ranked Tier 1 for Patent Prosecution UK in MIP IP STARS 2022.
Anna Mudge - May 24, 2022 Recipe for success - intellectual property opportunities in future food The future of food is big business and it’s only going to get bigger as both technology and ...
Alison Fugard - May 12, 2022 Life in plastic Plastic is prevalent in all areas of society, as is the growing awareness of its environmental ...
James Leach - May 11, 2022 Talking with machines: AI, language, and cognition “A reader lives a thousand lives before they die”. From Homer to Sophocles, Shakespeare to Orwell, ...
Thomas Wolter - April 27, 2022 Plausibility strikes again – BMS blockbuster apixaban patent found invalid by UK High Court In a recent judgment the UK High Court of Justice revoked European Patent (UK) 1 427 415 B1 and a ...
Adam Gregory - March 30, 2022 Five patenting pitfalls in future food (and how to avoid them) In our series on future food, we have explored the exciting innovations in areas such as cultured ...
Florian Zobel - March 30, 2022 2022 changes to EPO Guidelines: highlights With the 2021 changes to the examination guidelines, the EPO changed its schedule for issuing ...
Johannes Biniok - March 15, 2022 Has Russia allowed patent theft? In response to a decree issued by the Russian Government[1] on 6 March, various media outlets have ...
Samuel Hart - February 4, 2022 EPO announces fee increases from 1 April 2022 In recent times, the European Patent Office (EPO) has increased its official fees every two years. ...
Eliot Ward - January 19, 2022 As the UPC preparatory period begins, the EPO decides to accept UP requests before the full UPC agreement comes into force On 18 January 2022, Austria became the thirteenth EU country to ratify the “protocol on ...
Tom Furnival - December 24, 2021 Board of Appeal confirms DABUS AI cannot be an inventor for a European patent application On 21st December 2021 the EPO rejected the two appeals filed by Dr Thaler concerning whether an ...
Jonathan Wills - December 15, 2021 EPO Boards of Appeal to relocate back to Munich The President of the EPO has recently announced a plan to move the Boards of Appeal back to the ...
Eliot Ward - December 3, 2021 Austrian parliament unanimously passes legislation to allow the practical preparations for the UPC to begin On 2 December 2021, Austria became the thirteenth EU country to pass the “protocol on provisional ...
Jacqueline Murphy - October 26, 2021 New Green IP Report launched To coincide with the launch of COP26 we have released a new report into Green IP. Our report ...
Jacqueline Murphy - October 22, 2021 Chambers & Partners 2022 Legal Guide - Band 1 Recommended Firm We are delighted to have once again been ranked Band 1 in Chambers & Partners 2022 legal guide ...
Jacqueline Murphy - October 4, 2021 MIP IP Stars - The Rising Stars in IP 2021 Congratulations to Rebecca Anderson-Smith, Callum McGuinn and Ben Tolley for being recognised as ...
Isobel Stone - October 1, 2021 ‘IP Access’ fund, an extension of the existing UK IPO IP Audits Plus program In 2021, innovation really has been a hot topic, with the government’s Innovation Strategy ...
Jacqueline Murphy - September 30, 2021 Mewburn Ellis: top tier firm Legal 500 2022 Mewburn Ellis is proud to be ranked top tier for our patent and trade mark practices in the 2022 ...
Richard Johnson - September 22, 2021 DABUS decision: AI cannot be patent inventor, UK Court of Appeal rules On 21 September 2021, the UK Court of Appeal rejected an appeal raised by Dr. Stephen Thaler, who ...
Tanis Keirstead - September 8, 2021 A Unified Patents Court in 2022? The next hurdle in the way of the Unified Patent Court (UPC) opening its doors has now been ...
Katherine Green - September 6, 2021 Most opposed patents of 2020 Every year at the EPO about 3000-4000 patents are opposed. This figure represents only about 3-4% ...
Graeme Moore - August 24, 2021 New Innovation Strategy for the UK Last month the UK government launched a new Innovation Strategy, which seems to blend a long-term ...
Robert Watson - August 12, 2021 Intellectual property landscape 2021 - key questions answered Partner Robert Watson recently participated in a Corporate LiveWire virtual round table where ...
Robert Watson - July 2, 2021 Seeing Double at the EPO – what was G4/19 actually about? Whether double patenting, the granting of more than one patent for the same invention, should be ...
Jacqueline Murphy - July 2, 2021 IAM Patent 1000: The World’s Leading Patent Professionals 2021 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Rachel Collier - July 1, 2021 EPO Rule 19 EPC change regarding inventor addresses There has been a recent change to Rule 19 EPC which concerns inventorship information required by ...
Emma Kennaugh-Gallacher - June 28, 2021 Exhausted by Brexit? On 7 June 2021, the UK Intellectual Property Office (UKIPO) launched its consultation on the UK’s ...
Jacqueline Murphy - June 23, 2021 Pharma and Life Sciences Patent Extensions in Europe Our Special Report Pharma and Life Sciences Patent Extensions in Europe examines five years of data ...
Jacqueline Murphy - June 17, 2021 Mewburn Ellis ranked Tier 1 for Patent prosecution in MIP IP STARS 2021 We are delighted to be ranked Tier 1 for Patent Prosecution UK in MIP IP STARS 2021. As one of only ...
Finn Dinneen - June 17, 2021 Financial Times Special Report - Europe's Leading Patent Law Firms 2021 We are delighted to once again be recognised in the Financial Times Special Report Europe’s Leading ...
Rob Walker - June 1, 2021 World Bicycle Day: a history of bicycles through patents 3rd June 2021 marks the 4th World Bicycle Day, which, in the words of the UN, recognises the ...
Christoph Moeller - May 27, 2021 Community registered designs may claim priority to a PCT application within 12 months, European Court of Justice rules In a recent case (T-579/19), the European Court of Justice (ECJ) had to decide what the ...
Emma Kennaugh-Gallacher - May 21, 2021 Patent Settlement Agreements with a “Pay for Delay” element – restrictive ‘by object’? Almost two decades ago the European Commission (EC) launched a significant and far-reaching ...
Camille Terfve - May 20, 2021 Intellectual property and artificial intelligence in the UK: what might the future hold? AI is a hot topic for the current UK government. Last year, the UK Intellectual Property Office ...
Daniel Brodsky - April 14, 2021 Patenting a software invention at the UKIPO: a case study In a recent success for one of our clients, we overcame an objection raised by the UKIPO that the ...
Sarah Harvey - March 23, 2021 EPO 2020 Patent Index - key trends The European Patent Office (EPO) recently published its 2020 Patent Index which provides a ...
Dan Thornton - March 19, 2021 The UK tech sector – alive and kicking Tech Nation recently published their latest report on the state of the UK tech sector in 2020. ...
Urs Ferber - March 16, 2021 Patent litigation in Germany - an overview Germany – Europe’s largest economy – is an important market with respect to sales and investments ...
Eleanor Maciver - March 12, 2021 Selection inventions before the EPO Chemical inventions are subject to the same criteria as all inventions at the European Patent ...
Robert Watson - March 11, 2021 Defending D-Line From its first steps in North Shields to international stature, how has this company’s approach to ...
James Leach - March 11, 2021 EPO confirms that the COMVIK approach to assessing patent eligibility is applicable to computer simulations (G1/19) The Enlarged Board of Appeal (EBoA) has now issued their decision G1/19, which concerns the ...
Rebecca Tollervey - March 2, 2021 Patenting highly engineered antibodies in Europe In recent years, antibody engineering has moved into a new phase of complexity, with a ...
Richard Johnson - March 1, 2021 Developments in patenting activity in the Fourth Industrial Revolution Humans generate a mind-boggling amount of data each day. This explosion in data has stimulated ...
Dan Thornton - February 23, 2021 IP rights and company performance – a causal connection? We believe that IP can play an important positive role in commercial success, and in particular in ...
Urs Ferber - February 22, 2021 Updates to the EPO Guidelines 2021 The long awaited EPO Guidelines update has now been published (albeit in an unedited, provisional ...
Dan Thornton - February 17, 2021 Confidence with patent documents as a technical resource What is a patent document and why could it be useful to your R&D team? A patent confers upon ...
Robert Watson - February 16, 2021 Robert Watson appointed to EPO’s Standing Advisory Committee (SACEPO) Robert Watson has been appointed to the EPO’s Standing Advisory Committee (SACEPO) for its ...
Chris Denison - February 10, 2021 New EPO Guidelines for Examination of Antibody Inventions A new edition of the EPO examination guidelines will come into force on 1 March 2021. The EPO has ...
Sean Jauss - February 4, 2021 Protecting your intellectual property: top tips for start-ups It is common currency that intellectual property (IP) is an important and valuable asset of any ...
Jacqueline Murphy - February 4, 2021 New Special Report: Validation Strategies for Pharmaceutical Patents in Europe We are excited to announce the launch of our new Validation Strategies for Pharmaceutical Patents ...
Alex Burns - January 26, 2021 How to patent your digital health apps – 5 key considerations As the technical capabilities of smartphones continue to rise at an exponential rate, so too do the ...
Dan Thornton - December 17, 2020 Why building and nurturing an IP culture in your business is important Intellectual property (“IP”) – patents in particular – form a key pillar of many technology ...
Kate O'Rourke - December 16, 2020 Brexit has happened - what you need to know about the impact on trade marks Kate O’Rourke sets out the principles for UK and EU trade mark protection which came into force ...
Tanis Keirstead - December 14, 2020 New appointments signal rapid growth for Mewburn Ellis in Munich We have continued to demonstrate impressive growth with a series of new hires in our Munich office ...
James Leach - December 7, 2020 Software inventions at the European Patent Office: an in-depth study It is sometimes difficult to obtain patent protection for inventions relating to software, in part ...
Urs Ferber - December 1, 2020 Düsseldorf Regional Court refers Nokia vs. Daimler licensing dispute to CJEU As anticipated, the Düsseldorf Regional Court, in its decision Nokia ./. Daimler (4c O 17/19) ...
Tanis Keirstead - November 27, 2020 Further constitutional challenges to Unified Patent Court Agreement On 26 November 2020, the German Bundestag approved the ratification bill for the Unified Patent ...
Kate O'Rourke - November 20, 2020 UKIPO confirms new ‘Address for Service’ rules CITMA is celebrating a major victory on Brexit in the wake of the UKIPO’s latest “address for ...
Rebecca Tollervey - October 30, 2020 Highly-engineered antibodies: evolving the patent strategy In recent years, antibody engineering has moved into a new phase of complexity, with a ...
Jacqueline Murphy - October 23, 2020 Chambers & Partners 2020 Legal Guide - Band 1 Recommended Firm We are pleased to report that Mewburn Ellis has been ranked Band 1 in Chambers & Partners 2020 ...
Jacqueline Murphy - October 22, 2020 MIP IP STARS: The Rising Stars in IP 2020 Congratulations to Rebecca Anderson-Smith, Callum McGuinn and Ben Tolley for being recognised as ...
Matthew Smith - October 13, 2020 The UK Patent Box - is it delivering? Patent Box legislation has been very much in vogue over the last few years. At their heart, such ...
Jacqueline Murphy - October 1, 2020 Mewburn Ellis: top tier firm Legal 500 2021 We are delighted to be ranked top tier for our patent practice in the 2021 edition of The Legal ...
Fay Allen - September 24, 2020 More like the real meal - alternative plant-based proteins Plant-based protein alternatives have arrived in the UK in a big way, where sales of meat-free ...
Juliana Murray - September 23, 2020 Computer-implemented inventions at the UKIPO: a case review As discussed in our Patentability of Software and Business Method Inventions in Europe information ...
Adam Gregory - September 14, 2020 Trust at the dinner table: public perception and regulation of novel food technologies The history of humanity is the history of food technology. From the moment early hominids developed ...
Nick Sutcliffe - September 11, 2020 Pepper decision means conventionally bred plants and animals get a chilli reception at the EPO Dr Ben Tolley and Dr Nick Sutcliffe of the Life Sciences team look at the extensive ramifications ...
Urs Ferber - September 10, 2020 IP protection for 3D printed inventions 3D printing, known in industry as “additive manufacturing”, has emerged as one of the most ...
Thomas Lonsdale - September 7, 2020 Compostable packaging – let’s break it down Before Covid-19, I often used to buy my lunch in one of those “compostable” cardboard soup ...
Joseph Newcombe - September 2, 2020 Polymorphism: crystal clear or murky water Movers and shapeshifters in the world of solid state chemistry Have you ever left a bar of ...
Adam Gregory - August 24, 2020 Is the future of meat animal-free? Compelling advancements in cellular science could soon see us choosing to abandon animal ...
Katherine Green - August 21, 2020 Most Opposed Patents of 2019 The four thousand or so European patents that are opposed every year represent only about 3% of all ...
Simon Kiddle - August 20, 2020 Oppositions & Appeals: we helped clear a new path to patenting dosage regimes Case 10 – T 1020/03 (EPO Board of Appeal, 29 October 2004)
Urs Ferber - August 18, 2020 Nokia vs. Daimler - FRAND defence does not apply Breaking News in Nokia vs. Daimler (2 O 34/19) - (FRAND/SEP case)
Andrew Fearnside - August 17, 2020 Quantum computing: Why qubits have consequences for IP As part of our Thought Leaders series, Mewburn Ellis Senior Associate Andrew Fearnside explores ...
James Leach - August 12, 2020 Five things you (really) need to know about patenting software in Europe We often receive enquiries asking whether a particular software-related invention might be eligible ...
Genevieve Pugh - August 11, 2020 3D printing and its layers of legal complexity “3D printing” was first developed in the 1980s as a technique for rapid prototyping. Since then, 3D ...
Adam Gregory - August 3, 2020 Cellular Agriculture – forecasting innovation In their recent article in Nature Food, high-profile figures in the field of Cellular Agriculture – ...
Ben Boyd - July 29, 2020 Amazon and Zoox steer toward the development of self-driving delivery vehicles Amazon has agreed to acquire self-driving start-up Zoox for USD $1.2 billion (£975 million). This ...
Kate O'Rourke - July 29, 2020 The Intellectual Property Enterprise Court - ongoing success for brand owners Since 1990 businesses seeking to defend their intellectual property (IP) rights in the UK have had ...
Sofia Arenal - July 28, 2020 Oreo vs Twins - the biscuit wars Since 2015, two major biscuit manufacturers, have been doing battle, first at the EUIPO and then on ...
Seán Walton - July 24, 2020 Oppositions & Appeals: novelty of a patient sub-population Case 9 – T 734/12 (EPO Board of Appeal, 17 May 2013)
Victoria Coleman - July 21, 2020 UK formally withdraws from the UPC In a statement to Parliament on 20 July 2020, the government formally confirmed the UK’s withdrawal ...
Chris Denison - July 21, 2020 Are functional foods worth the fuss? Forward: features discuss and celebrate the best of innovation and exploration from the scientific ...
Frances Salisbury - July 16, 2020 Five tips for patenting inventions in personalised and stratified medicine As medical treatments become increasingly bespoke, we reveal some best practices to ensure that you ...
Urs Ferber - July 15, 2020 Landmark judgement in German FRAND case Sisvel vs. Haier On May 5, 2020, the Cartel Senate of the German Federal Supreme Court (BGH) held the oral hearing ...
Camille Terfve - July 14, 2020 Can software be therapeutic? The simple answer is: yes. Thanks for reading this post, stay tuned for more answers to your ...
Alexander Cavell - July 7, 2020 Tesla: Driving battery development differently “Invention is the most important product of man’s creative brain. The ultimate purpose is the ...
Camille Terfve - July 6, 2020 Protecting IP in bioinformatics and digital health: tips and tricks to tackle the “moving target problem” As previously discussed, data driven approaches have revolutionised research and R&D in the ...
Thomas Lonsdale - July 2, 2020 E-scooters – a solution to socially distanced travel? The UK Government has announced that trials of rental e-scooters will be allowed to take place from ...
Alex Burns - July 1, 2020 Right to repair: could it take a bite out of e-waste? Forward: features are independent pieces written for Mewburn Ellis discussing and celebrating the ...
Nick Sutcliffe - June 29, 2020 Supreme Court confirms strict line on insufficiency in the UK On 24 June 2020, the UK Supreme Court (UKSC) confirmed the UK courts’ strict approach to sufficient ...
Simon Kiddle - June 29, 2020 Oppositions & Appeals: we helped determine the meaning of “surgery” Case 8 – T 1695/07 (EPO Board of Appeal, 28 September 2011)
Melodie Richardson - June 24, 2020 Increasing battery capacity: going Si high Lithium-ion batteries can be found in almost every portable electrical device we use today. Our ...
Camille Terfve - June 23, 2020 A Guide to Patenting Bioinformatics Inventions at the EPO: what is technical and why does it matter? Many inventions in the field of bioinformatics (a term that we will use herein to encompass ...
Paul Dunne - June 23, 2020 Patenting bioplastics The push towards a circular economy promises huge rewards for innovators able to develop ...
Helen Bower - June 19, 2020 Financial Times: Europe's Leading Patent Law Firms 2020 We are delighted to once again be recognised in the Financial Times’ annual report on Europe’s ...
Jacqueline Murphy - June 16, 2020 IAM Patent 1000: The World’s Leading Patent Professionals 2020 We are delighted to once again be ranked ‘highly recommended’ in ‘IAM 1000: The World’s Leading ...
Niles Beadman - June 15, 2020 Patents driving tyre innovation From the outside, tyres appear unassumingly simple. But below the tread, they are deceptively ...
Camille Terfve - June 3, 2020 Have we entered the era of the DIY superhuman? Self-improvement products are everywhere around us, on our bookshelves and supermarket shelves ...
Julie Carlisle - June 1, 2020 Is faster drug development likely to become the “new normal?” As part of our Thought Leaders series, Sarah Kostiuk-Smith explores whether faster drug development ...
Willum Wytenburg - May 29, 2020 COVID-19: Suspension of Surcharge for Late Payment of Renewal Fees at the EPO The European Patent Office (EPO) now has a dedicated webpage regarding their response to COVID-19; ...
Nick Sutcliffe - May 19, 2020 G3/19 The Enlarged Board of Appeal has its cake and eats it On 14 May 2020, the Enlarged Board of Appeal of the European Patent Office (EBA) released their ...
Simon Kiddle - May 18, 2020 Oppositions & Appeals: We helped shape the debate on medical use claim patentability Case 7 – T 879/12 (EPO Board of Appeal, 27 August 2014)
Adam Gregory - May 15, 2020 New coronavirus (COVID-19) test allows rapid detection of neutralising antibodies Our client, Duke-NUS, has helped to develop a new, rapid serological test for determining whether ...
Thomas Driver - May 14, 2020 BREAKING: G3/19 – an end to the plant patentability saga? On 14 May 2020, the Enlarged Boards of Appeal of the European Patent Office released their decision ...
Richard Clegg - May 14, 2020 Singapore's biotech breakthrough From the far east to the east coast of America, the world is taking note of a new energy surging ...
Joseph Newcombe - May 7, 2020 InVEntions of WWII VE day on Friday 8 May 2020 is the 75th anniversary of the end of WWII in Europe. In 1945 the day ...
Jacqueline Murphy - May 5, 2020 IP STARS 2020: The leading practitioners in IP Congratulations to Sofia Arenal, Chris Denison, Stephen Gill, Sean Jauss, Kate O’Rourke, Nick ...
Willum Wytenburg - May 1, 2020 Coronavirus (COVID-19) extension at the EPO: Part 2 The European Patent Office (EPO) now has a dedicated webpage regarding their response to COVID-19; ...
Robert Andrews - April 30, 2020 BerGenBio’s bemcentinib selected for fast track as potential treatment for coronavirus (COVID-19) In the fight against the coronavirus pandemic, bemcentinib produced by BerGenBio has been selected ...
Andrew Pitts - April 24, 2020 Governments look to protect companies from IP enforcement during the coronavirus (COVID-19) pandemic A large effort is underway globally to ensure that there are enough mechanical ventilators ...
Matthew Naylor - April 9, 2020 Crown Use during the coronavirus (COVID-19) pandemic As discussed in a previous blog, the UK Government has the power to authorise (either in advance, ...
Andrew Pitts - April 3, 2020 Patent infringement during a national emergency: a Coronavirus (COVID-19) perspective Recent interesting reports highlight an emerging practice borne out of necessity in which medical ...
Maria Hall - April 1, 2020 New partner promotion and director appointments We are delighted to announce five new roles across three of our offices.
Tanis Keirstead - March 26, 2020 German Constitutional Court Verdict: Stumbling Block or Death Knell for the UPC? On 20 March 2020, three years after the challenge was originally brought, the German Constitutional ...
Eliot Ward - March 25, 2020 Microbiome: Meet your multitude The health and wellbeing of each of us depends upon a number of vast communities of microbes that ...
Willum Wytenburg - March 16, 2020 Coronavirus (COVID-19) Extension at the EPO: Not ALL deadlines extended! Part 2 of this blog was published on 17 April 2020. Please read for the latest information. News ...
Sean Jauss - March 11, 2020 Making Waves I guess it isn't all that surprising that it was tricky to get Nick Hounsfield and Craig Stoddart ...
Sarah Kostiuk-Smith - March 6, 2020 Why 'innoversity' is an imperative Andrea Brewster, lead executive officer at IP Inclusive, writes for Forward magazine. She discusses ...
Anna Mudge - February 19, 2020 What makes Massachusetts small but mighty? Deirdre Sanders, president of the Boston Patent Law Association and a principle at Hamilton Brook ...
Richard Clegg - February 12, 2020 Oppositions & Appeals: we opened the door for different types of data to support a medical use Case 4 - T 801/06 (EPO Board of Appeal, 4 March 2009)
Maria Hall - February 3, 2020 Munich office expansion with high-profile lateral hire We are delighted to announce the high-profile appointment of Dr. Thomas Wolter into our Munich ...
Simon Kiddle - January 29, 2020 Oppositions & Appeals: We made the case for a new technical effect Case 3 - T 1642/06 (EPO Board of Appeal, 23 August 2007)
Willum Wytenburg - January 27, 2020 EPO announces fee increases from 1 April 2020 In recent times, the European Patent Office (EPO) has increased its official fees every two years. ...
Jacqueline Murphy - January 23, 2020 Proud Partners of the Graphene Engineering Innovation Centre (GEIC) We are proud and excited to be starting our second year as an affiliate partner of the Graphene ...
Camille Terfve - January 23, 2020 Simulations in bioinformatics and the G1/19 referral What’s all this about? Claims directed to methods of simulation or modelling of a system or process ...
Sean Constable - January 17, 2020 EPO Board of Appeal confirms Broad Institute’s CRISPR patent lacks priority and upholds revocation decision In one of the most high profile cases of recent years, a European Patent Office (EPO) Board of ...
Jacqueline Murphy - January 8, 2020 JUVE Patent UK ranking 2020 We are delighted to be recommended in JUVE's Patent UK ranking 2020 which recognises patent ...
Matthew Smith - December 18, 2019 Graphene Composites: 5 things we can learn from the IP data The European Patent Office (EPO) recently released some initial data about patenting activity in ...
Anna Mudge - December 18, 2019 Will biomarkers come of age? The world’s population is ageing. In 2018, for the first time in history, people aged 65 or above ...
Alison Fugard - December 18, 2019 Sustainability: Graphene offers new opportunities In our blog Green graphene - the pursuit of sustainability we looked at methods for the production ...
Camille Terfve - December 16, 2019 Bioinformatics: biological and medical sciences in the age of big data What is bioinformatics? Bioinformatics is a term which we will use as an umbrella to encompass work ...
Camille Terfve - December 16, 2019 Bioinformatics is everywhere! As discussed in a previous post, most types of biological or medical data that can be collected ...
Isobel Stone - December 16, 2019 Collagen scaffolds – the future of tissue engineering? Despite the success of organ transplantation since its inception in the 20th century, people today ...
Rachel Oxley - December 11, 2019 Indian Patent Office adopts the Patent Prosecution Highway programme Recently, the Indian Union Cabinet approved a proposal for the Indian Patent Office (IPO) to adopt ...
Eliot Ward - December 6, 2019 Gamma/delta T cells emerge as an untapped resource for cancer immunotherapy Third lymphocyte lineage shows its mettle B lymphocytes, a type of white blood cell that is ...
William Hey - November 28, 2019 Australian innovation patent system - the end is near The Australian innovation patent system is on its last legs, which could spell bad news for SMEs ...
Anna Mudge - November 27, 2019 Biomarkers and precision medicine A biomarker, an amalgamation of the term ‘biological marker’, is a measurable indicator of a ...
Callum McGuinn - November 20, 2019 Lithium-ion batteries - powering the EVs of the future In a recent blog, Eleanor Maciver reviewed a variety of promising “batteries of the future”. Of ...
Matthew Smith - November 18, 2019 Graphene Hackathon 16-17 November 2019 saw a momentous occasion: innovators, creators and thinkers came together for ...
Maria Hall - November 14, 2019 New report launched: EPO Opposition Trends in the Life Sciences Sector Our new research has revealed several recent patterns regarding the European Patent Office ...
Katherine Green - November 14, 2019 EPO oppositions: Nine key questions answered Mewburn Ellis has dug deep into a decade of EPO life sciences' decisions to discover fresh insights ...
Callum McGuinn - November 12, 2019 Using IP to secure opportunities in the budding medical cannabis sector The opportunities for innovation in medical cannabis dovetails with the opportunity to obtain ...
Rebecca Tollervey - November 11, 2019 Top tips for patenting antibodies in Europe Antibody development is a mature field of technology. There are relatively few new targets, and the ...
Simon Parry - November 11, 2019 Extreme fast charging – the future of electric vehicle batteries With global deployment now exceeding five million, electric vehicles continue to hold the promise ...
Seán Walton - November 11, 2019 Oppositions a case to remember: we forced a fuller view of technical features Case 1 – T 1859/08 ( EPO Board of Appeal, 5 June 2016)
Simon Kiddle - November 8, 2019 Meet The Team: Simon Kiddle, Partner, European Patent Attorney As part of our 'meet the team' series, we talk to Simon Kiddle about his journey to becoming a ...
Andrew Pitts - November 6, 2019 Coffee capsules: greener grounds Large consumer companies are increasingly focusing on reworking their consumable products to be ...
Katherine Green - November 5, 2019 Meet The Team: Katherine Green, Partner, European Patent Attorney As part of our 'meet the team' series, we talk to Katherine Green about her journey to becoming a ...
Niles Beadman - October 30, 2019 Printing the unprintable – new technique expands graphene printing to previously unsuitable substrates Printing with graphene is a large and growing field, representing a highly promising range of ...
Camille Terfve - October 30, 2019 EPO Bioinformatics Roadshow There is still a relatively prevalent view in the field of bioinformatics and medical informatics ...
Alexander Cavell - October 30, 2019 Plastics recycling: polymers unzipped As society becomes more aware of the adverse effects of single-use plastics on the environment, ...
Katherine Green - October 30, 2019 Oppositions - a case to remember. Flexibility around added matter Case 2 – T 0099/13 (EPO Board of Appeal, 14 January 2016)
Emily Hayes - October 28, 2019 Meet The Team: Emily Hayes, Partner, European Patent Attorney As part of our 'meet the team' series, we talk to Emily Hayes about her journey to becoming a ...
Urs Ferber - October 26, 2019 FRAND Licensing of SEPs in the age of connected cars Cars are developing more and more into computerized mobile platforms. They relieve the driver of ...
Sean Constable - October 25, 2019 Employing CRISPR to expose ‘hiding’ cancer cells to immunotherapy Immunotherapy employs the patient’s immune system against cancer. There are various types of ...
Thomas Driver - October 23, 2019 Renewable energy – huge potential for biofuel innovation It has been widely reported in the media recently that we need to do more to address the way in ...
Nick Sutcliffe - October 21, 2019 Controlling genes – the new field of epitranscriptomics The human genome contains roughly 20,000 genes that encode proteins. In order for the cells and ...
Andrew Pitts - October 16, 2019 Infecting the infection to tackle the rise in chemical antibiotic resistance In previous blogs we have highlighted how certain families of bacteria are highly resistant to ...
Niles Beadman - October 9, 2019 Consumable consumables: the edible water bottle Throughout the 20th century, plastic has become increasingly prevalent in our everyday lives. To ...
Richard Johnson - October 7, 2019 Inventive AI: can machines innovate? The integration of technology based on artificial intelligence into our everyday lives continues ...
Julie Carlisle - September 27, 2019 AMR - a global threat A hot topic on everyone’s lips at the moment is Climate Change and its predicted impact on our way ...
Adam Gregory - September 26, 2019 T cell engagers - dark horses of immunotherapy Chimeric antigen receptor (CAR) technology has attracted a lot of attention and investment in ...
Callum McGuinn - September 26, 2019 Budding opportunities for pharma With shifting attitudes surrounding cannabis-based drugs, it is essential to explore the array of ...
Joseph Newcombe - September 25, 2019 From data to drugs - a brief introduction to AI in drug discovery The road to an approved drug is well known to be an arduous journey. Recent estimates put the cost ...
Matthew Smith - September 24, 2019 Strict and inflexible: material claims at the EPO Innovators in advanced materials can face an uphill struggle to get suitable patent protection at ...
Tanis Keirstead - September 19, 2019 Obtaining patent protection for fermentation processes and products – the European perspective Fermented foods have been known for millennia and form an important part of many national cuisines. ...
Eleanor Maciver - September 18, 2019 Batteries for the future: the sky may not be the limit! In an earlier blog Sam Bailey discussed the growing demands for high performance battery ...
Simon Parry - September 13, 2019 Intermodality: the future of transport? Search the term 'intermodality' and you'll turn up a number of definitions and some fine ...
Simon Kremer - September 11, 2019 Food of the future – regulating and protecting gene-edited crops A recent episode of the BBC World Service’s excellent series “50 Things that made the modern ...
Richard Johnson - September 6, 2019 When AI met EQ Affective computing may be a multi-billion -dollar business, but much of how it works remains ...
Camille Terfve - September 4, 2019 DIY biology dilemma – regulating biohacking Science kits may have inspired generations of children to become scientists, and those grown up ...
Matthew Naylor - August 30, 2019 Printing with graphene: exploring the inks set to unleash graphene's potential Graphene has been widely heralded as a game-changer in the research and development of new ...
Nick Sutcliffe - August 29, 2019 Shifting treatments: cancer as a manageable disease As new treatments drive a shift towards treating cancer as a manageable disease we are seeing ...
Simon Parry - August 20, 2019 Fast times at TBRe: the future of autonomous vehicles In Forward magazine edition 2, we met up with Team Bath Racing Electric (TBRe) who are driving the ...
Camille Terfve - August 15, 2019 Patentable subject matter in bioinformatics - USPTO’s January 2019 guidance In this article, Paul Liu and Ashley Barton from Duane Morris LLP provided some interesting ...
Richard Clegg - August 13, 2019 Challenges Post Selex Twenty-five years ago Tuerk and Gold reported the Selex method. Being the first European patent ...
Eleanor Maciver - August 7, 2019 Speeding things up at the EPO There are many reasons why an applicant may wish to speed up the prosecution of an application. For ...
Frances Salisbury - August 5, 2019 The rise of predictive medicine Thanks to significant advances in genetics, we are not only getting better at diagnosing disease, ...
Matthew Smith - July 31, 2019 Green graphene - the pursuit of sustainability Theoretically, at least, graphene can be produced from any carbon source. While the pursuit of ...
Simon Parry - July 31, 2019 The rise of e-scooters - micromobility gains momentum As congestion in cities rises, existing transportation can no longer keep up with growing ...
Adam Gregory - July 23, 2019 Cultured meat - food for thought Cultured meat is rapidly emerging alongside plant-and microorganism-based alternative meat products ...
Tom Furnival - July 12, 2019 EPO Quality Report 2018 July has seen the publishing of the European Patent Office’s (EPO) 2018 Quality Report. This is the ...
Emily Hayes - July 9, 2019 New Rules of Procedure at the Boards of Appeal – what does this mean for patentees and opponents? Revised Rules of Procedure at the Boards of Appeal have been approved by The Administrative Council ...
Emily Hayes - July 5, 2019 A Myriad of effects Even though the decision in Myriad is now 6 years old and there have been several follow-on cases, ...
Sam Bailey - June 27, 2019 Charging into the future - the increasing demands on battery technologies Battery technology is an area of constant innovation. For years we have been trying to squeeze a ...
Simon Parry - June 26, 2019 Data and security issues in a world of connected cars Mobility patterns are changing and technological innovations in electrification, connectivity and ...
Frances Salisbury - June 26, 2019 Gender medicine – deriving novelty from treating women? When you hear the term “gender medicine”, what comes to mind? For many people, the term is ...
Adam Gregory - June 21, 2019 Singapore biotech start-ups: the importance of patent protection Singapore’s biotech industry plays a key role in shaping the country’s future economy. This is ...
Callum McGuinn - June 18, 2019 Medicinal cannabis: recent changes and future innovations Government policy on the prescription of cannabis-derived medicines has undergone some interesting ...
Jacqueline Murphy - June 17, 2019 Managing Intellectual Property: IP Stars 2019 We are delighted to be ranked in Managing Intellectual Property: IP Stars for 2019.
Jacqueline Murphy - June 17, 2019 IAM Patent 1000, 2019 We are delighted to be ranked highly recommended in ‘IAM 1000: The World’s Leading Patent ...
Frances Salisbury - June 4, 2019 EU approves first gene therapy for patients with a mild form of β-Thalassemia Exciting news in the personalised medicine space – the EU has just approved the first gene therapy ...
Graeme Moore - May 29, 2019 The journey of rLoop - a new technology innovation network disrupting the world of transport and IP As a child growing up in Blackburn, near Manchester, UK, Ilyas Vali dreamed of owning a dog. He ...
Simon Parry - May 24, 2019 A single to Singapore please: the rise in on-demand bus services Discussion about future mobility tends to focus on the strategies of the major car manufacturers ...
Julie Carlisle - May 20, 2019 Protecting the ‘Trojan horse’ drug key to keeping a struggling field viable An Expert View column originally published in The Pharma Letter. Read the original article here. ...
Adam Gregory - May 17, 2019 Precision therapeutics for the precision medicine era In recent years we have seen dramatic advances in our understanding of the intricate and dynamic ...
Simon Kiddle - April 29, 2019 Personalised medicine: patient stratification While the general idea of customising treatment to patients is not new, the degree to which ...
Frances Salisbury - April 15, 2019 Pioneers of precision medicine Breakthroughs in healthcare promise a future in which the individual sits at the centre of medical ...
Simon Parry - April 5, 2019 Hydrogen fuel cell vehicles: growth and innovation While much attention and noise has surrounded the growth in the number of electric and plug-in ...
Matthew Smith - April 4, 2019 Hydrogen: the storage question There’s a lot to like about hydrogen. It’s light; it’s abundant (at least atomically - water and ...
Matthew Smith - March 28, 2019 Advanced materials: game-changing graphene In the 15 years since Professors Andre Geim and Konstantin Novoselov isolated and discovered ...
Julie Carlisle - March 28, 2019 Dosage regimen patents: bruised but not beaten Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court has found ICOS’s Cialis patent ...
Emily Hayes - March 25, 2019 Playing for time: strategies that can help extend a drug's patent life In our new magazine Forward, we interview C Hunter Baker of Wolf, Greenfield & Sacks PC. Hunter ...
Maria Hall - March 11, 2019 Former CITMA President Kate O’Rourke to head our European trade mark services We are delighted to announce that Kate O’Rourke will join the firm on 1 April 2019.
Sean Constable - March 6, 2019 EPO oral proceedings in Haar - do they infringe a party’s right to be heard? A new referral to the Enlarged Board raises this question... The right to be heard under Article ...
Frances Salisbury - February 27, 2019 Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences We are entering an age of precision medicine, with patients receiving tailored treatments, selected ...
Emma Graham - February 26, 2019 How to patent AI technology at the EPO Once only a figment of the imagination in literature such as Mark Shelley’s Frankenstein, ...
Simon Parry - February 25, 2019 Self-driving vehicles: what do consumers think (and want)? As a survey of 25,000 consumers in 20 countries, and a study that has been conducted annually over ...
Simon Kiddle - February 22, 2019 Is your interest legitimate? New referral to the EBOA on double patenting EPO Board of Appeal 3.3.01 is referring a number of questions regarding double patenting to the ...
Matthew Smith - February 15, 2019 Building an IP portfolio: Nine tips for success Companies need to think carefully about how they protect, manage and leverage the various ...
Thomas Driver - February 6, 2019 Plant related inventions: clarity at last? As we reported previously, EPO Technical Board of Appeal 3304 recently ruled that a controversial ...
Frances Salisbury - February 4, 2019 Fighting cancer with CAR-T therapies In September 2018, NHS England entered into an agreement with Novartis to offer its CAR-T therapy, ...
Emily Hayes - January 30, 2019 Commercialising genomic research in the US: tips for obtaining patent protection The field of genomics has seen incredible advances over the past few decades. Technological ...
Frances Salisbury - January 30, 2019 China - a key player in the global precision medicine race With a growing economy, and a large, ageing population, China is attracting attention from global ...
Simon Parry - January 22, 2019 Autonomous vehicles - the race to innovate The future of the automotive sector will be fundamentally different from its past. Electric ...
Sean Jauss - January 14, 2019 Eight key themes from the J.P. Morgan Healthcare Conference I’ve spent the last few days talking with biotech entrepreneurs, VC fund managers and lawyers ...
Graeme Moore - December 13, 2018 Blockchain: the next patent boom Emma Graham and Graeme Moore attended the EPO’s “Patenting Blockchain” conference in The Hague – ...
Frances Salisbury - December 13, 2018 Precision medicine: ethics, regulation and patent law New genomic and proteomic analysis technologies allow for diagnosis and prognosis of patients with ...
Simon Parry - December 11, 2018 Future mobility: the new direction of transport Massive social, economic and technology trends are converging to change mobility - how we move ...
Frances Salisbury - December 10, 2018 Plant related inventions: the saga continues We may be approaching the end of the year, but the saga of patents for plant related inventions at ...
Adam Gregory - December 10, 2018 Patent protection: five tips for biotech start-ups Early-stage biotech companies are often founded based on the exciting results of pre-clinical ...
Richard Clegg - December 10, 2018 Clovis Oncology success in European Opposition Proceedings related to Rubraca® Clovis Oncology has announced that the European Patent Office (EPO) last week upheld claims of ...
Anna Mudge - December 2, 2018 The importance of Innovation Hubs in the UK's North West Region Life science ‘start-ups’, ‘spin-outs’ and SMEs are some of the most innovative businesses and are ...
Nick Sutcliffe - November 14, 2018 Supreme Court decision signals bad news for patent holders The UK Supreme Court issued its decision today on the Warner Lambert vs Generics (UK) Ltd t/a ...
Frances Salisbury - October 31, 2018 Precision Medicine: the next revolution in healthcare In recent years, we have witnessed a remarkable healthcare revolution. Thanks to advances in ...
Richard Clegg - October 31, 2018 Morphosis: creating and nurturing biotech start-ups in Singapore We understand that early-stage biotech companies do not have it easy. It is a long road from ...
Matthew Smith - October 29, 2018 Development in the war on superbugs The spread of antibiotic-resistant infections is one of the most serious threats in modern ...
Graeme Moore - October 19, 2018 Patenting board games and puzzles Quite a lot of people think of new games and puzzles, and wonder whether patenting would help them ...
Matthew Smith - October 8, 2018 JIPA 2018 European Seminar The Japanese Intellectual Property Association (JIPA) has been promoting fair and effective ...
Seán Walton - October 3, 2018 The pioneering work of Professor Sir Greg Winter Professor Sir Greg Winter’s pioneering work using phage display for the directed evolution of ...
Robert Watson - September 27, 2018 Navigating the Brexit landscape: patents The existing European patent system was unaffected by the UK leaving the EU earlier in 2020, and by ...
Simon Kremer - April 30, 2018 Changes to inter partes review system for challenging granted patents Last week, the U.S. Supreme Court issued two important decisions relating to inter partes review ...
Anna Mudge - April 20, 2018 Celebrating women working in IP in the North West On Thursday 19 April, we were proud hosts of an American Intellectual Property Law Association ...
Callum Anderson - August 1, 2017 UK Supreme Court Establishes Doctrine of Equivalents in Actavis v Lilly In many jurisdictions a product or process may be held to infringe even though it falls outside the ...
